MediciNova
Clinical trials sponsored by MediciNova, explained in plain language.
A biopharmaceutical company developing treatments for neurological and inflammatory diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill aims to tackle fatty liver and diabetes at once Results expected Dec 2026 (estimated)
- Could an old asthma drug slow ALS? new trial aims to find out Results expected Apr 2027 (estimated) 🚀 Make-or-break